E-LIB Suche - Ergebnisse für: J. A. Cortés

1

Gut microbiota and immune profiling of microbiota-humanised..:

Stark, K. A. ; Rinaldi, G. ; Costain, A....
Animal Microbiome. 6 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Insights into HER2-Low Status and the Breast Cancer Immune ..:

Di Cosimo, S. ; Pizzamiglio, S. ; Ciniselli, C.M....
European Journal of Cancer. 200 (2024) - p. 113864 , 2024

Link: https://doi.org/10.1016/..

3

189P The impact of high body mass index (BMI) on the safety..:

Estevez, L. García ; Bardia, A. ; Rugo, H.S....
ESMO Open. 9 (2024) - p. 103211 , 2024

Link: https://doi.org/10.1016/..

4

Enhancing efficiency and sustainability of digital light pr..:

Cortés, A. ; Bañón-Veracruz, M. ; Jiménez-Suárez, A....
Journal of Materials Research and Technology. 29 (2024) - p. 3237-3248 , 2024

Link: https://doi.org/10.1016/..

5

CRANIOFACIAL RECONSTRUCTION, USING BOX TECHNIQUE MOBILIZATI..:

Soza, A. Araya ; Cortes, J. ; Germain, F.
International Journal of Oral and Maxillofacial Surgery. 52 (2024) - p. 71-72 , 2024

Link: https://doi.org/10.1016/..

6

220P Impact of time to progression (TTP) on CDK4/6 inhibito..:

Llombart-Cussarc, A. ; García, J.M. Pérez ; Borrego, M. Ruiz...
ESMO Open. 9 (2024) - p. 103242 , 2024

Link: https://doi.org/10.1016/..

7

Circulating tumor DNA for predicting recurrence in patients..:

Nader-Marta, G. ; Monteforte, M. ; Agostinetto, E....
ESMO Open. 9 (2024) 3 - p. 102390 , 2024

Link: https://doi.org/10.1016/..

8

183MO Capivasertib and fulvestrant (F) for patients (pts) w..:

Rugo, H.S. ; Oliveira, M. ; Howell, S.J....
ESMO Open. 9 (2024) - p. 103205 , 2024

Link: https://doi.org/10.1016/..

9

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2..:

Hurvitz, S.A. ; Kim, S.-B. ; Chung, W.-P....
ESMO Open. 9 (2024) 5 - p. 102924 , 2024

Link: https://doi.org/10.1016/..

10

Magma recharge in persistently active basaltic–andesite sys..:

Cortés, J. A. ; Gertisser, R. ; Calder, E. S.
International Journal of Earth Sciences. 113 (2024) 5 - p. 1145-1163 , 2024

Link: https://doi.org/10.1007/..

11

74P Assessing the implementation of the HER2DX genomic test..:

Cejalvo, J.M. ; Soberino, J. ; Ciruelos, E.M....
ESMO Open. 9 (2024) - p. 103080 , 2024

Link: https://doi.org/10.1016/..

12

Neoadjuvant pembrolizumab or placebo + chemotherapy, follow..:

Cardoso, F. ; O'Shaughnessy, J. ; McArthur, H....
European Journal of Cancer. 200 (2024) - p. 113608 , 2024

Link: https://doi.org/10.1016/..

13

EE291 Schizophrenia and Bipolar Disorder Burden and Economi..:

Colimon, S ; Cortes, J ; Agudelo, C.
Value in Health. 27 (2024) 6 - p. S111 , 2024

Link: https://doi.org/10.1016/..

14

Shifting the paradigm: Improving renal cell carcinoma stagi..:

Saitta, C. ; Afari, J. ; Lane, B....
European Urology. 85 (2024) - p. S174-S175 , 2024

Link: https://doi.org/10.1016/..

15

133P Molecular profile and actionability of sarcomas with n..:

Zugman, M. ; Fernandes, M. ; de Lima, L....
ESMO Open. 9 (2024) - p. 102522 , 2024

Link: https://doi.org/10.1016/..